Organotypic explant culture of glioblastoma multiforme and subsequent single-cell suspension

Current Protocols in Stem Cell Biology

Volumn , Issue SUPPL.19, 2011, Pages

  Shimizu, Fumiko ^a   Hovinga, Koos E ^b   Metzner, Michael ^c   Soulet, Denis ^d,e   Tabar, Viviane ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b UNIVERSITY OF AMSTERDAM   (Netherlands)

^c FLORIDA ATLANTIC UNIVERSITY   (United States)

^d UNIVERSITÉ LAVAL   (Canada)

^e LAVAL UNIVERSITY   (Canada)

Author keywords

3D culture system; Cancer stem cells; Endothelial cells; Explants; Glioblastoma multiforme (GBM); Organotypic cultures; Tumor stroma

Indexed keywords

ARTICLE; CANCER CELL CULTURE; CELL SUSPENSION; CYTOARCHITECTURE; EXPLANT; GLIOBLASTOMA; HUMAN; IN VITRO STUDY; PRESERVATION; PRIORITY JOURNAL; SINGLE CELL ANALYSIS; THREE DIMENSIONAL IMAGING; TUMOR CELL; METHODOLOGY; ORGAN CULTURE TECHNIQUE; PATHOLOGY; SUSPENSION; TUMOR CELL CULTURE;

GLIOBLASTOMA; HUMANS; ORGAN CULTURE TECHNIQUES; SINGLE-CELL ANALYSIS; SUSPENSIONS; TUMOR CELLS, CULTURED;

EID: 84857623812     PISSN: 19417322     EISSN: 19388969     Source Type: Journal    
DOI: 10.1002/9780470151808.sc0305s19     Document Type: Article

References (19)

1. Beier, D., Hau, P., Proescholdt, M., Lohmeier, A., Wischhusen, J., Oefner, P.J., Aigner, L., Brawanski, A., Bogdahn, U., and Beier, C.P. 2007. CD133(+) and CD133(-) glioblastomaderived cancer stem cells show differential growth characteristics and molecular profiles. Cancer Res. 67:4010-4015.
2. Calabrese, C., Poppleton, H., Kocak, M., Hogg, T.L., Fuller, C., Hamner, B., Oh, E.Y., Gaber, M.W., Finklestein, D., Allen, M., Frank, A., Bayazitov, I.T., Zakharenko, S.S., Gajjar, A., Davidoff, A., and Gilbertson, R.J. 2007. A perivascular niche for brain tumor stem cells. Cancer Cell 11:69-82.
3. Clement, V., Marino, D., Cudalbu, C., Hamou, M.F., Mlynarik, V., de Tribolet, N., Dietrich, P.Y., Gruetter, R., Hegi, M.E., and Radovanovic, I. 2010. Marker-independent identification of glioma-initiating cells. Nat. Methods 7:224-228.
4. De Witt Hamer, P.C., Van Tilborg, A.A.G., Eijk, P.P., Sminia, P., Troost, D., Van Noorden, C.J.F., Ylstra, B., and Leenstra, S. 2008. The genomic profile of human malignant glioma is altered early in primary cell culture and preserved in spheroids. Oncogene 27:2091-2096.
5. Ferrari, D., Binda, E., De Filippis, L., and Vescovi, AL. 2010. Isolation of neural stem cells from neural tissues using the neurosphere technique. Curr. Protoc. Stem Cell Biol. 15:2D.6.1-2D.6.18.
6. Gähwiler, B.H., Capogna, M., Debanne, D., McKinney, R.A., and Thompson, S.M. 1997. Organotypic slice cultures: A technique has come of age. Trends Neurosci. 20:471-477.
7. Galli, R., Binda, E., Orfanelli, U., Cipelletti, B., Gritti, A., De Vitis, S., Fiocco, R., Foroni, C., Dimeco, F., and Vescovi, A. 2004. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64:7011-7021.
8. Hovinga, K.E., Shimizu, F., Wang, R., Panagiotakos, G., Van Der Heijden, M., Moayedpardazi, H., Correia, A.S., Soulet, D., Major, T., Menon, J., and Tabar, V. 2010. Inhibition of notch signaling in glioblastoma targets cancer stem cells via an endothelial cell intermediate. Stem Cells 28:1019-1029.
9. Inda, M.M., Bonavia, R., Mukasa, A., Narita, Y., Sah, D.W., Vandenberg, S., Brennan, C., Johns, T.G., Bachoo, R., Hadwiger, P., Tan, P., Depinho, R.A., Cavenee, W., and Furnari, F. 2010. Tumor heterogeneity is an active process maintained by a mutant EGFR-induced cytokine circuit in glioblastoma. Genes Dev. 24:1731-1745.
10. Joyce, J.A. 2005. Therapeutic targeting of the tumor microenvironment. Cancer Cell 7:513-520.
11. Jung, S., Kim, H.W., Lee, J.H., Kang, S.S., Rhu, H.H., Jeong, Y.I., Yang, S.Y., Chung, H.Y., Bae, C.S., Choi, C., Shin, B.A., Kim, K.K., and Ahn, K.Y. 2002. Brain tumor invasion model system using organotypic brain-slice culture as an alternative to in vivo model. J. Cancer Res. Clin. Oncol. 128:469-476.
12. Lee, J., Kotliarova, S., Kotliarov, Y., Li, A., Su, Q., Donin, N.M., Pastorino, S., Purow, B.W., Christopher, N., Zhang, W., Park, J.K., and Fine, H.A. 2006. Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines. Cancer Cell 9:391-403.
13. Li, A., Walling, J., Kotliarov, Y., Center, A., Steed, M.E., Ahn, S.J., Rosenblum, M., Mikkelsen, T., Zenklusen, J.C., and Fine, H.A. 2008. Genomic changes and gene expression profiles reveal that established glioma cell lines are poorly representative of primary human gliomas. Mol. Cancer Res. 6:21-30.
14. Pallini, R., Ricci-Vitiani, L., Banna, G.L., Signore, M., Lombardi, D., Todaro, M., Stassi, G., Martini, M., Maira, G., Larocca, L.M., and De Maria, R. 2008. Cancer stem cell analysis and clinical outcome in patients with glioblastoma multiforme. Clin. Cancer Res. 14:8205-8212.
15. Pollard, S.M., Yoshikawa, K., Clarke, I.D., Danovi, D., Stricker, S., Russell, R., Bayani, J., Head, R., Lee, M., Bernstein, M., Squire, J.A., Smith, A., and Dirks, P. 2009. Glioma stem cell lines expanded in adherent culture have tumor-specific phenotypes and are suitable for chemical and genetic screens. Cell Stem Cell 4:568-580.
16. Singh, S.K., Hawkins, C., Clarke, I.D., Squire, J.A., Bayani, J., Hide, T., Henkelman, R.M., Cusimano, M.D., and Dirks, P.B. 2004. Identification of human brain tumour initiating cells. Nature 432:396-401.
17. Son, M.J., Woolard, K., Nam, D.H., Lee, J., and Fine, H.A. 2009. SSEA-1 is an enrichment marker for tumor-initiating cells in human glioblastoma. Cell Stem Cell 4:440-452.
18. Stoppini, L., Buchs, P.A., and Muller, D. 1991. A simple method for organotypic cultures of nervous tissue. J. Neurosci. Methods 37:173-182.
19. Sutherland, R.M. 1988. Cell and environment interactions in tumor microregions: The multicell spheroid model. Science 240:177-184.